Skip to content

Search Results

No Matching Results

    Recently Viewed

      Listening...

      HomeLatest newsHow Johnson & Johnson is working to create a healthier planet
      Four pictures show a scientist; a mother and child; businesspeople shaking hands; a woman outside; and wind turbines

      How Johnson & Johnson is working to create a healthier planet

      For World Health Day, learn about the rapid progress the company is making toward its commitment to creating a cleaner, safer environment around the globe.

      Share Article
      share to

      Wonder how much progress Johnson & Johnson is making toward its ambitious goals to help protect the health of our planet?
      Short answer: A lot.

      In fact, the company has made considerable strides in transitioning to renewable electricity and is more than half of the way toward meeting the goal of sourcing 100% of electricity needs at its facilities around the world from renewable sources by 2025.

      But what does that mean exactly?

      • Today, Johnson & Johnson is announcing that it has signed a new power purchase agreement that will bring the company to 100% renewable electricity at its operations in the United States and Canada by 2023.
      • The new sources of energy will come from a new solar field in the United States with a generation capacity of 55 megawatts or approximately 117,000 megawatt hours of renewable electricity annually—leading to a reduction in greenhouse gas emissions that’s the equivalent of taking more than 18,000 cars off the road each year. These add to the existing on- and off-site renewable electricity capacity that powers Johnson & Johnson operations in North America.
      • With this news, and three new wind and solar agreements the company made in Europe in July, nearly all Johnson & Johnson sites in Europe, the United States and Canada will be powered with 100% renewable electricity by 2023.

      The benefit: Generating electricity from low-carbon energy sources decreases emissions of harmful gases, according to the Harvard T.H. Chan School of Public Health, and helps to mitigate climate change, which the World Health Organization recently called the single biggest threat to the health of humanity.

      This is all part of how Johnson & Johnson is accelerating its longstanding commitment to help improve the health of our planet through three ambitious goals it plans to meet in the areas of renewable electricity, carbon neutrality for its operations and value chain emissions reductions.

      To learn more, check out Johnson & Johnson’s full list of Health for Humanity 2025 Goals.

      More from Johnson & Johnson

      Meet a nurse who leads clinical trials to find innovative cancer therapies

      Melissa Martinez is a clinical scientist within Johnson & Johnson’s Interventional Oncology R&D group. Not only is she helping to develop lifesaving treatments, she’s redefining what it means to pursue a career in nursing.

      What’s the difference between IBS and IBD?

      These GI conditions sound similar, and they also share some symptoms. But IBS and IBD are distinct disorders—especially when it comes to treatment and the risk of complications.

      What is IL-23?

      This pro-inflammatory protein is the target of potential Johnson & Johnson medications that could help treat autoimmune conditions such as psoriasis, inflammatory bowel disease and rheumatoid arthritis.
      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.